CN Patent

CN101679408A — 作为fgfr抑制剂的双环杂环化合物

Assigned to Astex Therapeutics Ltd · Expires 2010-03-24 · 16y expired

What this patent protects

本发明涉及新颖双环杂环衍生化合物、包含所述化合物的医药组合物和所述化合物用于治疗疾病如癌症的用途。

USPTO Abstract

本发明涉及新颖双环杂环衍生化合物、包含所述化合物的医药组合物和所述化合物用于治疗疾病如癌症的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN101679408A
Jurisdiction
CN
Classification
—
Expires
2010-03-24
Drug substance claim
No
Drug product claim
No
Assignee
Astex Therapeutics Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.